Position in BIIB
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,113,187
+$1,668,877 QoQ
Shares Held
56,064
-1.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#157
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $290,206,318 across 12 Drug Manufacturers - General names. BIIB ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
411,773 | $78,080,395 | |
| 2 | LLY |
ELI LILLY & Co
|
52,884 | $63,430,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
399,582 | $51,346,286 | |
| 4 | PFE |
Pfizer Inc
|
1,455,651 | $35,052,075 | |
| 5 | JNJ |
Johnson & Johnson
|
78,892 | $20,036,200 | |
| 6 | ABBV |
AbbVie Inc.
|
49,869 | $12,549,032 | |
| 7 | BIIB |
Biogen Inc.
This page
|
56,064 | $12,113,187 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
83,510 | $10,550,651 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,113,187 | 56,064 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $10,444,310 | 56,970 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,786,050 | 66,970 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,381,157 | 66,970 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,495,211 | 59,680 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,219,978 | 60,070 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,185,903 | 60,070 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $11,643,968 | 60,070 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,960,199 | 60,220 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,868,798 | 59,680 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $12,455,375 | 48,133 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $12,373,745 | 48,145 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,068,376 | 28,325 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,849,342 | 28,232 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,805,737 | 35,410 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $10,450,380 | 39,140 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $11,618,461 | 56,970 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,263,938 | 67,730 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $17,292,233 | 72,075 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $17,348,135 | 61,303 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,672,180 | 45,260 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $12,941,235 | 46,260 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,123,483 | 37,260 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $10,569,916 | 37,260 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,968,913 | 37,260 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $9,630,607 | 30,440 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||